During the final presidential debate, research finally got some airtime. President Barack Obama noted that “… if we don’t continue to put money into research and technology that will allow us to create great businesses here in the United States, that’s how we lose to the competition.” Similarly, Mitt Romney emphasized his support for research, saying that “I want to invest in research, providing funding to universities … is great.”
It was great to hear both candidates acknowledge the importance of research for the future. As they explained, investment in research is crucial for supporting universities, creating jobs and maintaining America’s competitive edge (three of Research!America’s Top 10 Reasons Why the U.S. Should Invest in Global Health R&D). Research is also essential in protecting the health of the American people, as highlighted recently by a bipartisan group of Texas representatives.
On October 12, 21 Texas representatives sent a letter to the Department of Health and Human Services and the Centers for Disease Control and Prevention asking for more action to address the West Nile virus outbreak. Mentioning the significant burden of West Nile in Texas and throughout the country (4,725 cases and 219 fatalities this year alone), legislators requested that the agencies prioritize the development of a FDA-approved West Nile vaccine. Government-funded projects have made progress toward a West Nile vaccine in the past, and additional research investment could help to turn these vaccine candidates into a reality. Research to develop a vaccine is particularly important in light of new information on the long-term burden of West Nile. Recent studies have shown that 40% of West Nile patients still have severe, productivity-limiting symptoms several years after contracting the virus. Other researchers have discovered a link between the virus and chronic kidney disease, even among patients that did not show any West Nile symptoms originally.
In addition to the public health benefits of a West Nile vaccine, research investment into other neglected tropical diseases (NTDs) could also save American lives. NTDs like Chagas disease and dengue fever affect thousands of Americans every day, and political leaders must prioritize research for new prevention and treatment methods to fight these diseases around the globe and here at home.
-Morgan McCloskey, global health intern